US3117128A
(en)
|
|
1964-01-07 |
|
Certificate of correction |
US3116284A
(en)
|
|
1963-12-31 |
|
Chs chj |
CH312963A
(de)
|
1953-03-10 |
1956-03-15 |
Sandoz Ag |
Verfahren zur Herstellung von Azofarbstoffen
|
GB853799A
(en)
|
1957-11-21 |
1960-11-09 |
Pfizer & Co C |
Diquaternary compounds and process of preparing same
|
GB884258A
(en)
|
1958-11-06 |
1961-12-13 |
Ciba Ltd |
A new quinone derivative
|
GB1237126A
(en)
|
1968-04-10 |
1971-06-30 |
Agfa Gevaert Nv |
3-acyl-amino-pyrazolin-5-ones
|
US3577462A
(en)
|
1968-08-08 |
1971-05-04 |
American Home Prod |
N-arylalkyl-beta-hydroxy-beta-phenyl-ethylamines and the salts thereof
|
US3966809A
(en)
|
1973-11-19 |
1976-06-29 |
Stauffer Chemical Company |
Insect repellent compounds
|
US4257954A
(en)
|
1978-08-08 |
1981-03-24 |
Sterling Drug Inc. |
Novel compounds, processes and marking systems
|
US4535087A
(en)
|
1982-11-19 |
1985-08-13 |
Chevron Research Company |
N-Substituted phenoxyacetamide fungicides
|
US4672065A
(en)
|
1982-11-19 |
1987-06-09 |
Chevron Research Company |
N-substituted phenoxyacetamide fungicides
|
US4859707A
(en)
|
1983-08-23 |
1989-08-22 |
Key Pharmaceuticals, Inc. |
Sulfur-substituted phenylacetamides
|
JPS6127905A
(ja)
|
1984-07-18 |
1986-02-07 |
Hokko Chem Ind Co Ltd |
除草剤
|
JPS6127955A
(ja)
|
1984-07-18 |
1986-02-07 |
Hokko Chem Ind Co Ltd |
アリ−ルスルホニル脂肪酸アミド誘導体、その製造法および除草剤
|
JPS6127905U
(ja)
|
1984-07-25 |
1986-02-19 |
本田技研工業株式会社 |
Ohc型内燃機関
|
JPS61126071A
(ja)
|
1984-11-22 |
1986-06-13 |
Hokko Chem Ind Co Ltd |
農園芸用殺菌剤
|
DE3600950A1
(de)
|
1986-01-15 |
1987-07-16 |
Bayer Ag |
5-acylamido-1-aryl-pyrazole
|
DE3636278A1
(de)
|
1986-10-24 |
1988-05-05 |
Hoechst Ag |
Herbizide mittel auf der basis von cyclischen (alpha)-iminocarbon-saeureaniliden sowie neue (alpha)-iminocarbonsaeureanilide und verfahren zu ihrer herstellung
|
CA2071897A1
(en)
|
1989-12-28 |
1991-06-29 |
Richard A. Glennon |
Sigma receptor ligands and the use thereof
|
CA2096970C
(en)
|
1990-11-26 |
1998-07-14 |
Masakazu Sato |
Anilide derivative
|
US5362878A
(en)
|
1991-03-21 |
1994-11-08 |
Pfizer Inc. |
Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
|
CA2077252C
(en)
|
1992-08-31 |
2001-04-10 |
Khashayar Karimian |
Methods of making ureas and guanidines, and intermediates therefor
|
IL107120A
(en)
|
1992-09-29 |
1997-09-30 |
Boehringer Ingelheim Int |
Atomising nozzle and filter and spray generating device
|
US5256658A
(en)
|
1993-01-15 |
1993-10-26 |
Ortho Pharmaceutical Corporation |
Angiotensin II inhibitors
|
US5428037A
(en)
|
1993-04-09 |
1995-06-27 |
Syntex Pharmaceuticals, Ltd. |
Heterocyclic derivatives in the treatment of Ischaemia and related diseases
|
DE4319039A1
(de)
|
1993-06-08 |
1994-12-15 |
Bayer Ag |
Substituierte (2-Oxo-1-benzimidazolinyl)-piperidine, Verfahren zu ihrer Herstellung und Verwendung als anti-retrovirale Mittel
|
US5834490A
(en)
|
1993-11-04 |
1998-11-10 |
Instituto De Investigacion Y Desarrolo Quimico Biologico, S.A. |
Cyclopropyl derivatives, preparation method there-of and applications
|
US5583147A
(en)
|
1994-03-23 |
1996-12-10 |
The Dupont Merck Pharmaceutical Company |
Amides for the treatment of atherosclerosis
|
US5491170A
(en)
|
1994-12-19 |
1996-02-13 |
Warner-Lambert Company |
β-carboxy sulfonamide ACAT inhibitors
|
WO1996026925A1
(fr)
|
1995-03-01 |
1996-09-06 |
Banyu Pharmaceutical Co., Ltd. |
Derives de l'arylthioacetamide
|
DE19536902A1
(de)
|
1995-10-04 |
1997-04-10 |
Boehringer Ingelheim Int |
Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
|
DE19536903C2
(de)
|
1995-10-04 |
1998-09-10 |
Boehringer Ingelheim Int |
Vorrichtung zum Haltern eines fluidischen Bauteils
|
DE19545226C1
(de)
|
1995-12-05 |
1997-06-19 |
Boehringer Ingelheim Int |
Sperrspannwerk für einen federbetätigten Abtrieb
|
EP0906310A4
(en)
|
1996-06-07 |
1999-09-01 |
Merck & Co Inc |
OXADIAZOLE-BENZOSULFONAMIDES AS SELECTIVE BETA-3 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETIS AND OBESITY
|
US5808453A
(en)
|
1996-08-21 |
1998-09-15 |
Siliconix Incorporated |
Synchronous current sharing pulse width modulator
|
ATE294172T1
(de)
|
1996-09-13 |
2005-05-15 |
Schering Corp |
Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren
|
CN1158254C
(zh)
|
1996-09-27 |
2004-07-21 |
法玛西雅厄普约翰美国公司 |
作为基质金属蛋白酶抑制剂的β-磺酰基异羟肟酸
|
US5968929A
(en)
|
1996-10-30 |
1999-10-19 |
Schering Corporation |
Piperazino derivatives as neurokinin antagonists
|
US6048900A
(en)
|
1998-02-13 |
2000-04-11 |
Bayer Corporation |
Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists
|
NZ337331A
(en)
|
1997-02-21 |
2001-05-25 |
Bayer Ag |
Aryl-sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
|
SK115799A3
(en)
|
1997-02-27 |
2000-09-12 |
American Cyanamid Co |
N-HYDROXY-2-(ALKYL, ARYL OR HETEROARYL SULFANYL, SULFINYL ORì (54) SULFONYL)-3-SUBSTITUTED ALKYL, ARYL OR HETEROARYLAMIDES
|
US5958940A
(en)
|
1997-09-11 |
1999-09-28 |
Schering Corporation |
Tricyclic compounds useful as inhibitors of farnesyl-protein transferase
|
DE69811273T2
(de)
|
1997-11-21 |
2003-12-11 |
Upjohn Co |
Alpha-hydroxy, -amino und -fluoro derivate von beta-sulfonylhydroxamsäuren als matrixmetalloproteinasen-inhibitoren
|
US6528529B1
(en)
|
1998-03-31 |
2003-03-04 |
Acadia Pharmaceuticals Inc. |
Compounds with activity on muscarinic receptors
|
US6359009B1
(en)
|
1998-04-08 |
2002-03-19 |
Basf Aktiengesellschaft |
Substituted anilide insecticidal agents
|
GB9810671D0
(en)
|
1998-05-18 |
1998-07-15 |
Pfizer Ltd |
Anti-pruritic agents
|
US6756404B2
(en)
|
1998-06-18 |
2004-06-29 |
The Research & Development Institute, Inc. |
Autoinducer compounds
|
US6337347B1
(en)
|
1998-06-18 |
2002-01-08 |
The Research & Development Institute, Inc. |
Autoinducer compounds
|
ATE329911T1
(de)
|
1998-08-07 |
2006-07-15 |
Applied Research Systems |
Fsh mimetika zur behandlung von infertilität
|
AR023171A1
(es)
|
1999-03-26 |
2002-09-04 |
Cocensys Inc |
Pirazoles, imidazoles, oxazoles, tiazoles, y pirroles sustituidos por arilo, y el uso de los mismos.
|
DE19929076A1
(de)
|
1999-06-25 |
2000-12-28 |
Aventis Pharma Gmbh |
Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
US6355653B1
(en)
|
1999-09-06 |
2002-03-12 |
Hoffmann-La Roche Inc. |
Amino-triazolopyridine derivatives
|
AU780572B2
(en)
|
1999-10-18 |
2005-04-07 |
University Of Connecticut, The |
Pyrazole derivatives as cannabinoid receptor antagonists
|
AR035912A1
(es)
|
2000-03-02 |
2004-07-28 |
Aventis Cropscience Sa |
Compuestos de 4-tiometilpirazol, composicion plaguicida, metodo para el control de plagas en un lugar, semillas tratadas o recubiertas,uso de estos compuestos o composiciones para el control de plagas, uso de estos compuestos para preparar un medicamento veterinario, y,proceso para la preparacion de
|
AU2001274598A1
(en)
|
2000-06-23 |
2002-01-02 |
Mitsubishi Pharma Corporation |
Antitumor effect potentiators
|
BR0116388A
(pt)
|
2000-12-22 |
2003-09-30 |
Astrazeneca Ab |
Composto, processo para preparar um composto, composição farmacêutica e método para tratar, em um animal de sangue quente, distúrbios de alimentação e uso de um composto
|
US20020099035A1
(en)
|
2001-01-24 |
2002-07-25 |
Sandanayaka Vincent P. |
Method for preparing alpha-sulfonyl hydroxamic acid derivatives
|
US7067539B2
(en)
|
2001-02-08 |
2006-06-27 |
Schering Corporation |
Cannabinoid receptor ligands
|
US7507767B2
(en)
|
2001-02-08 |
2009-03-24 |
Schering Corporation |
Cannabinoid receptor ligands
|
WO2002088089A1
(fr)
|
2001-04-19 |
2002-11-07 |
Banyu Pharmaceutical Co., Ltd. |
Derives de spiropiperidine, antagonistes du recepteur de nociceptine les contenant en tant qu'ingredient actif et compositions medicinales
|
EP1436250A1
(en)
|
2001-10-04 |
2004-07-14 |
Novartis AG |
Cyanoacetyl compounds
|
AU2002363250A1
(en)
|
2001-11-01 |
2003-05-12 |
Icagen, Inc. |
Pyrazole-amides and-sulfonamides
|
JP2003155285A
(ja)
|
2001-11-19 |
2003-05-27 |
Toray Ind Inc |
環状含窒素誘導体
|
WO2003055482A1
(en)
|
2001-12-21 |
2003-07-10 |
Novo Nordisk A/S |
Amide derivatives as gk activators
|
AU2003211629B8
(en)
|
2002-03-05 |
2009-01-22 |
Boehringer Ingelheim Animal Health USA Inc. |
5-substituted-alkylaminopyrazole derivatives as pesticides
|
EP1539693B9
(en)
|
2002-06-19 |
2008-10-08 |
Schering Corporation |
Cannabinoid receptor agonists
|
JP2006506340A
(ja)
|
2002-08-09 |
2006-02-23 |
アストラゼネカ アクチボラグ |
代謝調節型グルタミン酸受容体5のモジュレーターとしてのオキサジアゾール
|
JP2006502134A
(ja)
|
2002-08-09 |
2006-01-19 |
アストラゼネカ アクチボラグ |
代謝調節型グルタミン酸受容体において活性を有する化合物
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
AR041268A1
(es)
|
2002-09-19 |
2005-05-11 |
Solvay Pharm Bv |
Derivados de la 1h -1,2,4- triazol-3-carboxamida que tienen actividad agonista, agonista parcial, agonista inversa o antagonista del receptor cb 1 de cannabinoide y composiciones farmaceuticas que los contienen
|
GB0222495D0
(en)
|
2002-09-27 |
2002-11-06 |
Glaxo Group Ltd |
Compounds
|
BR0314611A
(pt)
|
2002-10-09 |
2005-07-26 |
Pfizer Prod Inc |
Compostos de tiazol para o tratamento de distúrbios neurodegenerativos
|
US20050250814A1
(en)
|
2002-10-30 |
2005-11-10 |
Cangyou Zhou |
Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
|
US7642277B2
(en)
|
2002-12-04 |
2010-01-05 |
Boehringer Ingelheim International Gmbh |
Non-nucleoside reverse transcriptase inhibitors
|
SE0300010D0
(sv)
|
2003-01-07 |
2003-01-07 |
Astrazeneca Ab |
Novel Compounds
|
US7718692B2
(en)
|
2004-02-13 |
2010-05-18 |
Carson John R |
Hetero-substituted acetanilide derivatives as analgesic agents
|
DE10307845A1
(de)
|
2003-02-25 |
2004-09-02 |
Bayer Cropscience Gmbh |
Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
|
US7449464B2
(en)
|
2003-03-12 |
2008-11-11 |
Kudos Pharmaceuticals Limited |
Phthalazinone derivatives
|
SE0301372D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
CA2524511A1
(en)
|
2003-05-12 |
2004-11-18 |
Pfizer Products Inc. |
Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
|
JP2004337701A
(ja)
|
2003-05-14 |
2004-12-02 |
Seiko Epson Corp |
液滴吐出方法、及び液滴吐出装置
|
EP1658072A4
(en)
|
2003-08-21 |
2009-03-25 |
Pfizer Prod Inc |
Compounds for the Treatment of Neurodegenerative Diseases
|
EP1664010A1
(en)
|
2003-08-29 |
2006-06-07 |
Vernalis (R&D) Limited |
Sulfonamides antagonising n-type calcium channels
|
CN1956949A
(zh)
|
2003-09-18 |
2007-05-02 |
默克公司 |
取代的磺酰胺
|
WO2005030127A2
(en)
|
2003-09-23 |
2005-04-07 |
Merck & Co., Inc. |
Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
CA2542064A1
(en)
|
2003-10-24 |
2005-05-06 |
Exelixis, Inc. |
Tao kinase modulators and methods of use
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
CA2550012A1
(en)
|
2003-12-17 |
2005-06-30 |
Takeda Pharmaceutical Company Limited |
Urea derivative, process for producing the same and use
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
WO2005077368A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
US7585881B2
(en)
|
2004-02-18 |
2009-09-08 |
Astrazeneca Ab |
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
FR2866885B1
(fr)
|
2004-02-26 |
2007-08-31 |
Sanofi Synthelabo |
Derives de piperidinylalkylcarbamates, leur prepation et leur application en therapeutique
|
JP2007526324A
(ja)
|
2004-03-02 |
2007-09-13 |
スミスクライン・ビーチャム・コーポレイション |
Akt活性のある阻害剤
|
CN1934091B
(zh)
|
2004-03-23 |
2012-02-08 |
辉瑞产品公司 |
治疗神经变性障碍的咪唑化合物
|
US7232820B2
(en)
|
2004-04-01 |
2007-06-19 |
Pfizer Inc |
Thiadiazole-amine compounds for the treatment of neurodegenerative disorders
|
US8008020B2
(en)
|
2004-06-03 |
2011-08-30 |
Vermillion, Inc. |
Biomarkers for peripheral artery disease
|
JP2008504276A
(ja)
|
2004-06-24 |
2008-02-14 |
インサイト・コーポレイション |
アミド化合物およびその医薬としての使用
|
CA2589565A1
(en)
|
2004-06-24 |
2006-01-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
US8019436B2
(en)
|
2004-06-25 |
2011-09-13 |
Cochlear Limited |
Electrode assembly for a stimulating medical device
|
FR2872813B1
(fr)
|
2004-07-09 |
2007-01-19 |
Sanofi Synthelabo |
Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique
|
WO2006030805A1
(ja)
|
2004-09-16 |
2006-03-23 |
Astellas Pharma Inc. |
トリアゾール誘導体またはその塩
|
WO2006044645A2
(en)
|
2004-10-13 |
2006-04-27 |
Adolor Corporation |
Sulfamoyl benzamides and methods of their use
|
JP2006143667A
(ja)
|
2004-11-22 |
2006-06-08 |
Ube Ind Ltd |
ピペコリン酸アミド誘導体及び抗菌剤
|
ES2435790T3
(es)
|
2004-12-03 |
2013-12-23 |
Intervet International B.V. |
Piperazinas sustituidas como antagonistas de CB1
|
JP2008526887A
(ja)
|
2005-01-10 |
2008-07-24 |
ユニバーシティ オブ コネチカット |
カンナビノイド受容体に作用する新規なヘテロピロール類似体
|
WO2006080040A1
(en)
|
2005-01-25 |
2006-08-03 |
Università Degli Studi Di Siena |
New potent and selective ligands of cannabinoid receptors
|
GB0504753D0
(en)
|
2005-03-08 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
GB0506133D0
(en)
|
2005-03-24 |
2005-05-04 |
Sterix Ltd |
Compound
|
FR2885364B1
(fr)
|
2005-05-03 |
2007-06-29 |
Sanofi Aventis Sa |
Derives d'alkyl-, alkenyl-et alkynylcarbamates, leur preparation et leur application en therapeutique
|
WO2007020502A2
(en)
|
2005-08-16 |
2007-02-22 |
Pharmacia & Upjohn Company Llc |
Cannabinoid receptor ligands and uses thereof
|
KR100997595B1
(ko)
|
2005-11-08 |
2010-11-30 |
화이자 리미티드 |
피라졸 유도체 및 이의 의약 용도
|
JP2009519349A
(ja)
|
2005-12-15 |
2009-05-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cb2受容体を変調する化合物
|
WO2007080382A1
(en)
|
2006-01-11 |
2007-07-19 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives and their use in therapy
|
WO2007101270A1
(en)
|
2006-03-02 |
2007-09-07 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
WO2007102059A1
(en)
|
2006-03-06 |
2007-09-13 |
Pfizer Japan Inc. |
Sulfonyl benzimidazole derivatives
|
EP2007707A1
(en)
|
2006-04-07 |
2008-12-31 |
Boehringer Ingelheim International GmbH |
Compounds which modulate the cb2 receptor
|
MX2008015217A
(es)
|
2006-05-31 |
2008-12-12 |
Abbott Lab |
Compuestos de tiazol como ligandos del receptor de canabinoides y usos de los mismos.
|
EP2081905B1
(en)
|
2006-07-28 |
2012-09-12 |
Boehringer Ingelheim International GmbH |
Sulfonyl compounds which modulate the cb2 receptor
|
AU2007287428B2
(en)
|
2006-08-24 |
2011-08-11 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
|
CN101516839A
(zh)
|
2006-09-25 |
2009-08-26 |
贝林格尔.英格海姆国际有限公司 |
调节cb2受体的化合物
|
US7928103B2
(en)
|
2006-10-17 |
2011-04-19 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the CB2 receptor
|
WO2008064054A2
(en)
|
2006-11-21 |
2008-05-29 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
WO2008098025A1
(en)
|
2007-02-08 |
2008-08-14 |
Boehringer Ingelheim International Gmbh |
Arylsulfonamide compounds which modulate the cb2 receptor
|
US8940900B2
(en)
|
2007-02-28 |
2015-01-27 |
Advinus Therapeutics Private Limited |
2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
|
CA2702772A1
(en)
|
2007-10-25 |
2009-04-30 |
Boehringer Ingelheim International Gmbh |
Diazepane compounds which modulate the cb2 receptor
|
JP5492092B2
(ja)
|
2007-11-07 |
2014-05-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cb2受容体を調節する化合物
|
WO2009077533A1
(en)
|
2007-12-17 |
2009-06-25 |
Janssen Pharmaceutica Nv |
Fluoroalkyl substituted benzimidazole cannabinoid agonists
|
JP2011507910A
(ja)
|
2007-12-21 |
2011-03-10 |
ユニバーシティー オブ ロチェスター |
真核生物の寿命を変更するための方法
|
US8957063B2
(en)
|
2008-02-21 |
2015-02-17 |
Boehringer Ingelheim International Gmbh |
Amine and ether compounds which modulate the CB2 receptor
|
EP2418207A1
(en)
|
2008-05-13 |
2012-02-15 |
Boehringer Ingelheim International GmbH |
Sulfone compounds which modulate the CB2 receptor
|
JP5749162B2
(ja)
|
2008-07-10 |
2015-07-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cb2受容体を調節するスルホン化合物
|
BRPI0919172A2
(pt)
|
2008-09-25 |
2015-12-15 |
Boehringer Ingelheim Int |
compostos os quais modulam seletivamente o receptor de cb2
|
US8629157B2
(en)
|
2009-01-05 |
2014-01-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolidine compounds which modulate the CB2 receptor
|
US8889670B2
(en)
|
2009-02-18 |
2014-11-18 |
Boehringer Ingelheim International Gmbh |
Heterocyclic compounds which modulate the CB2 receptor
|
US8299103B2
(en)
|
2009-06-15 |
2012-10-30 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the CB2 receptor
|
EP2443107B1
(en)
|
2009-06-16 |
2018-08-08 |
Boehringer Ingelheim International GmbH |
Azetidine 2 -carboxamide derivatives which modulate the cb2 receptor
|
US20120277296A1
(en)
|
2009-07-23 |
2012-11-01 |
Sophie Lotersztajn |
Selective CB2 Receptor Agonists for Use in the Prevention or Treatment of Alcoholic Liver Disease
|
SG10201404925TA
(en)
|
2009-08-28 |
2014-10-30 |
Arena Pharm Inc |
Cannabinoid receptor modulators
|
EP2477963A4
(en)
|
2009-09-18 |
2013-02-27 |
Zalicus Pharmaceuticals Ltd |
ARYLSULFON DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
|
WO2011037795A1
(en)
|
2009-09-22 |
2011-03-31 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the cb2 receptor
|
WO2011088015A1
(en)
|
2010-01-15 |
2011-07-21 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
US8329735B2
(en)
|
2010-03-05 |
2012-12-11 |
Boehringer Ingelheim International Gmbh |
Tetrazole compounds which selectively modulate the CB2 receptor
|
EP2595959B1
(en)
|
2010-07-22 |
2015-11-04 |
Boehringer Ingelheim International GmbH |
Sulfonyl compounds which modulate the cb2 receptor
|
EP2803668A1
(en)
|
2013-05-17 |
2014-11-19 |
Boehringer Ingelheim International Gmbh |
Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
|